🇰🇷 Tresiba in South Korea

Tresiba (INSULIN DEGLUDEC) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Tresiba in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Tresiba approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Tresiba in South Korea?

Novo Nordisk is the originator. The local marketing authorisation holder may differ — check the official source linked above.